NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Outlook: Nifty 50 Falls Amid Global Cues, Weak Rupee

The domestic market benchmarks, the Sensex and the Nifty 50, ended half a percent lower on Thursday, 30 April, amidst adverse global cues. The Nifty 50 closed 180 points, or 0.74%, lower at 23,997.55, with 34 components in the red. Despite the decline, the index inched up by 0.42% on a weekly scale, while it gained 7% on a monthly basis after losing for the last four consecutive months.

The decline was primarily driven by higher crude oil prices, which spiked to their highest levels since 2022 amid tensions in West Asia and concerns over supply disruptions through the Strait of Hormuz. Additionally, weak global cues, the rupee's weakness, and continued foreign institutional outflows weighed on sentiment.

Market Trends: A Cautious Stance

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Ajit Mishra, Senior Vice President of Research at Religare Broking, highlighted that the ongoing tussle in the benchmark reflects a lack of conviction among participants amidst mixed cues. However, this phase is expected to resolve soon. Mishra pointed out that a decisive move below 23,800 in the Nifty could trigger further downside towards the 23,500 level or lower. On the upside, the 24,400–24,800 zone is likely to act as a strong resistance.

Short-Term Trading Strategies

Mishra recommended short-term trading strategies for three stocks: RBL Bank, Sun Pharma, and Tata Motors Passenger Vehicles.

StockRecommendationTarget PriceStop Loss
RBL BankBuy₹370₹320
Sun Pharmaceutical IndustriesBuy₹1,980₹1,720
Tata Motors Passenger VehiclesSell Futures₹322₹355

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Technical Analysis

RBL Bank's share price has recently witnessed a decisive breakout after consolidating within the ₹335–₹390 range for nearly six months, indicating the end of a consolidation phase and the potential start of a fresh uptrend. Sun Pharma shares have shown early signs of a potential trend reversal after undergoing a prolonged corrective phase for over a year. Tata Motors Passenger Vehicles stock continues to trade in a lower top–lower bottom structure, where recovery attempts have consistently been capped below prior swing highs, reflecting weak buying interest and sustained bearish control.

Trading Advice

Traders are advised to maintain a cautious stance, focus on risk management, and prefer sector-specific opportunities. Mishra suggested accumulating RBL Bank and Sun Pharma at current levels while monitoring volume sustainability and broader market cues for confirmation. A short position in Tata Motors Passenger Vehicles futures may be considered as per the specified levels.

Investor Takeaway

Investors should be cautious and wait for a decisive move below 23,800 in the Nifty before making any investment decisions.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.